What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

***OFFICIAL CYDY/Leronlimab Thread*** (3 Viewers)

So if Leronlimab prevents Covid from causing a "Bad" immunological state and harming your body and organs. Would this not be eqivilant to a vaccine except using the live virus? Obviously there would need to be testing to make sure there's no other harm being done and that immunity is lasting. 

 
[icon] said:
What it feels like to be a CYDY Long right now. :lol:  
Click to expand...
Not really and I fully acknowledge all the red flags.  I believe what Patterson is saying, if this guy turns out to be a quack, it will probably be a while before I trust any "expert" again.  He is the cornerstone to this investment. 

I'm okay with this drifting a little lower as Id like to buy more but am getting stubborn about getting the best price.

 
Walking Boot said:
Honestly, a real company CEO shouldn't really care about share price, unless it tanks so bad the shareholders decide to gang together and force him out of his job.

I mean, here's how it works: A company "goes public" by dividing itself up into a million shares and selling those shares on the stock market. If the company is worth $100mil, they presumably sell those shares to you, me, Chet, BassNBrew, etc. for $100 each. The company takes in $100mil in cash from the sales.

But, then, it's you, me, Chet, and BassNBrew selling our shares to other people. If we sell those shares at $500 each to some sucker like Otis... the company doesn't get any of that money. There's no return for them. If we sell those shares for $10 each to adonis and FreeBaGel, the company's "value" on paper goes down, but, it doesn't affect the company at all. They sold their shares already. A bunch of outsiders trading them back and forth like baseball cards doesn't do anything. (If a Mike Trout rookie card goes from $1 to $50 years after it's been sold, it doesn't affect the bottom line over at Topps, right?)

The CEO shouldn't worry about stock price. Unless the company is needs to show paper value somewhere, it's not affecting it at all.

Instead, here, we have NP paying the company money to some bogus "news channel" looking production company in order for them to ask him the questions he's scripted for them to ask him, every time it drops thirty cents... and for what? So it looks like he's "out in the media" when in reality, this company couldn't get Fox News or CNBC to return their calls if they tried. It's an awful look.
Click to expand...
They do want to get uplisted to Nasdaq so I assume there is at least some concern with the stock price there.

 
Walking Boot said:
Honestly, a real company CEO shouldn't really care about share price, unless it tanks so bad the shareholders decide to gang together and force him out of his job.

I mean, here's how it works: A company "goes public" by dividing itself up into a million shares and selling those shares on the stock market. If the company is worth $100mil, they presumably sell those shares to you, me, Chet, BassNBrew, etc. for $100 each. The company takes in $100mil in cash from the sales.

But, then, it's you, me, Chet, and BassNBrew selling our shares to other people. If we sell those shares at $500 each to some sucker like Otis... the company doesn't get any of that money. There's no return for them. If we sell those shares for $10 each to adonis and FreeBaGel, the company's "value" on paper goes down, but, it doesn't affect the company at all. They sold their shares already. A bunch of outsiders trading them back and forth like baseball cards doesn't do anything. (If a Mike Trout rookie card goes from $1 to $50 years after it's been sold, it doesn't affect the bottom line over at Topps, right?)

The CEO shouldn't worry about stock price. Unless the company is needs to show paper value somewhere, it's not affecting it at all.

Instead, here, we have NP paying the company money to some bogus "news channel" looking production company in order for them to ask him the questions he's scripted for them to ask him, every time it drops thirty cents... and for what? So it looks like he's "out in the media" when in reality, this company couldn't get Fox News or CNBC to return their calls if they tried. It's an awful look.
Click to expand...
It’s an awful look and he comes off like an amateur but it doesn’t really matter at all if the results good. 

 
Also as for the "bogus" news channel PR, I don't hate it as much as everyone else. Here's why.

They aren't getting any coverage by legit news sources but they do want to keep getting a message out so they aren't forgotten.  This is how NP thinks the company stays relevant, by him giving what seems like weekly conference calls and doing these proactive videos.  I do think that NP believes he is doing his shareholders a favor by constantly giving updates.  There is probably some truth to this and quite possibly the stock price wouldn't be as high as it is if we never heard about them.

Now the content could be better for sure, I won't argue that.

 
Walking Boot said:
Instead, here, we have NP paying the company money to some bogus "news channel" looking production company in order for them to ask him the questions he's scripted for them to ask him, every time it drops thirty cents... and for what? So it looks like he's "out in the media" when in reality, this company couldn't get Fox News or CNBC to return their calls if they tried. It's an awful look.
Click to expand...
Sponsored editorial/content is not an uncommon thing.  Is some sponsored content better than others?  Feel like its arguable because at the end of the day it's the same thing, the company is scripting the message any way they like.

 
Last edited by a moderator:
The thing is mass media won't cover the company unless there's trial results. So many companies, so many drugs, so many claims.

Guess what we're waiting for? Trial results.

Anything linked to covid with sucessful trial results has been getting coverage. 

We're either early to the party or it's just about to be midnight.

The production is bad but these videos actually make me believe NP more. If you were CEO of an OTC company that had a legitimate treatment for COVID that was in the verge of uplisting you need to care about stock price. It's a literal requirement for uplisting! Hopefully once they get uplisted his focus on sp goes away.

 
Last edited by a moderator:
We know what will happen in two scenarios with the early peak at the S/C trial.

If they stop it because the drug is showing no efficacy then the stock crashes.

If they stop it because the drug is saving lives, then the stock moons.

If they continue with the trial (which I think is a fairly positive thing), do you think the stock takes a big hit, or will it continue on its current path?

 
Chaz McNulty said:
We know what will happen in two scenarios with the early peak at the S/C trial.

If they stop it because the drug is showing no efficacy then the stock crashes.

If they stop it because the drug is saving lives, then the stock moons.

If they continue with the trial (which I think is a fairly positive thing), do you think the stock takes a big hit, or will it continue on its current path?
Click to expand...
Personally, I think it gets a little bump because it at least shows some promise that has been verified by someone other than a person with vested interest in the company.

I don't know how much of a bump that is, but I do think it bumps a little.

 
Certainly feels like this week is a big week.  Cases spiking, Trump desperate for good news, s/c trial review results and topline results possible, uplisting possibly a few weeks away, incelldx just putting on market test kits that support leronlimab usage.

Any day could be the day it takes off...but conversely, negative news could cause serious fallout.  The upside, from my perspective, seems higher than the downside though at this time.  Just a waiting game until the news comes out on any of those things - uplisting, s/c results, topline results.  

 
Last edited by a moderator:
adonis said:
Certainly feels like this week is a big week.  Cases spiking, Trump desperate for good news, s/c trial review results and topline results possible, uplisting possibly a few weeks away, incelldx just putting on market test kits that support leronlimab usage.

Any day could be the day it takes off...but conversely, negative news could cause serious fallout.  The upside, from my perspective, seems higher than the downside though at this time.  Just a waiting game until the news comes out on any of those things - uplisting, s/c results, topline results.  
Click to expand...
Or next week....maybe the week after....possibly a few weeks from now. 

But yah if you're still here you gotta be holding. We've have 2 KINGs and the dealer is showing a 6 is how I'm feeling.

 
Chaz McNulty said:
We know what will happen in two scenarios with the early peak at the S/C trial.

If they stop it because the drug is showing no efficacy then the stock crashes.

If they stop it because the drug is saving lives, then the stock moons.

If they continue with the trial (which I think is a fairly positive thing), do you think the stock takes a big hit, or will it continue on its current path?
Click to expand...
For your last scenario, "trial continues", which I think is the most probable, the stock price is going to tie back to what we know about the M/M trial.

If the M/M trial is inconclusive but we get a phase 3, then I think the price is going to continue to fluctuate a bit to the negative.  The longer it takes these trials to complete, the more pressure to the negative this is going to have.  I do think shorts would be more in control at this point.

If M/M trial does not even get a Phase 3, then obviously that negative pressure would be even more.

If they do prove efficacy with M/M and we get EUA, we are good.

 
Would love to find another country as a backup for these trials in case this drags out a lot longer in the USA.  Am disappointed this Mexico trial is not happening.  I know we are being told that Mexico wants to package it with another drug but this is all still a red flag, that Mexico doesn't even want to entertain it on its own.

My biggest concern is timing of approval and being surpassed.  Im fairly convinced we have a good candidate to be in the mix but have no confidence that the FDA thinks highly of Cytodyn and is going to give any leeway whatsoever to them.  They are going to be held to the highest standard and this could drag out.

 

 
Well guys, it was a good run.  No news after hours...pack it up, last one out turn the lights off when you leave the thread

 
You must log in or register to reply here.

Similar threads

wadegarrett
***Official OHIO STATE-MICHIGAN Thread***
40 41 42
Replies
2K
Views
52K
Blue Dot Orange Dot
B
Bob Magaw
*** Official 2011 St. Louis Rams Thread ***
Replies
21
Views
2K
Bob Magaw
Bob Magaw
Couch Potato
Couch Potato 2012 Dynasty Rankings
4 5 6
Replies
293
Views
40K
Spin
Spin

Users who are viewing this thread

Total: 3 (members: 0, guests: 3)
Back
Top